Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. 1995

Neurology. 2001 Dec;57(12 Suppl 5):S16-24.
No abstract available

Publication types

  • Biography
  • Classical Article
  • Historical Article

MeSH terms

  • Clinical Trials, Phase III as Topic / history
  • Disability Evaluation
  • Female
  • Glatiramer Acetate
  • History, 20th Century
  • Humans
  • Male
  • Multicenter Studies as Topic / history
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Multiple Sclerosis, Relapsing-Remitting / history*
  • Peptides / history*
  • Peptides / therapeutic use
  • Randomized Controlled Trials as Topic / history

Substances

  • Peptides
  • Glatiramer Acetate

Personal name as subject

  • K P Johnson
  • B R Brooks
  • J A Cohen
  • C C Ford
  • J Goldstein
  • R P Lisak
  • L W Myers
  • H S Panitch
  • J W Rose
  • R B Schiffer
  • T Vollmer
  • L P Weiner
  • J S Wolinsky